IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
9.03
-0.74 (-7.56%)
Nov 21, 2024, 1:50 PM EST - Market open
IGM Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 537 | 485 | 728 | 952 | 2,818 | 1,165 | |
| Market Cap Growth | 101.32% | -33.39% | -23.49% | -66.22% | 141.87% | - | |
| Enterprise Value | 408 | 139 | 287 | 722 | 2,651 | 934 | |
| Last Close Price | 9.77 | 8.31 | 17.01 | 29.33 | 88.29 | 38.16 | |
| PS Ratio | 201.73 | 227.82 | 681.46 | - | - | - | |
| PB Ratio | 7.35 | 2.39 | 2.54 | 3.89 | 7.38 | 4.85 | |
| P/TBV Ratio | 12.43 | 2.39 | 2.54 | 3.89 | 7.38 | 4.85 | |
| EV/Sales Ratio | 139.73 | 65.47 | 268.87 | - | - | - | |
| Debt / Equity Ratio | 0.58 | 0.20 | 0.14 | 0.12 | 0.03 | 0.06 | |
| Asset Turnover | 0.01 | 0.00 | 0.00 | - | - | - | |
| Quick Ratio | 5.00 | 7.97 | 9.57 | 8.26 | 21.25 | 25.31 | |
| Current Ratio | 5.22 | 8.18 | 9.81 | 8.67 | 21.65 | 26.04 | |
| Return on Equity (ROE) | -132.11% | -100.48% | -83.09% | -52.71% | -26.16% | -36.66% | |
| Return on Assets (ROA) | -37.38% | -34.91% | -35.11% | -29.24% | -15.54% | -20.96% | |
| Return on Capital (ROIC) | -69.34% | -57.16% | -47.33% | -30.95% | -16.04% | -21.81% | |
| Earnings Yield | -37.86% | -50.78% | -30.35% | -17.35% | -2.89% | -3.70% | |
| FCF Yield | -29.73% | -42.17% | -2.20% | -14.52% | -3.03% | -4.07% | |
| Buyback Yield / Dilution | -24.54% | -25.92% | -24.09% | -8.88% | -241.82% | -1953.40% | |
| Total Shareholder Return | -24.54% | -25.92% | -24.09% | -8.88% | -241.82% | -1953.40% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.